QLY Biotech Group Corp. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$0

Net Income/Loss (FY2022)

-$14.1K

Total Assets (FY2022)

$0

Total Equity (FY2022)

$0

Cash Flows from Operating Activities (FY2022)

-$14.2K

Source: QLY Biotech Group Corp. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.